BioSpace News Archive

CSafe Global chose Cloudleaf to help deliver the company’s new digital visibility platform to support their track and trace technology and ensure 24/7 data access that will allow customers to make informed decisions and protect medicines for patients worldwide.

Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today announced it is immediately readying testing samples of its GenViro! Covid-19 Swift Kits for testing in the US market and additional testing internationally

Check-Cap Ltd. announced that it has entered into a definitive agreement with several existing institutional investors for the exercise of certain outstanding warrants to purchase up to an aggregate of 16,054,223 of its ordinary shares at a reduced exercise price of $0.60 per share.

Scott D. Flora appointed as Chairman of the Board.

Innovative Patient-Centric Study Design Benefits Study Participants

Opthea Limited, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, is pleased to announce that clinical trial results from the Phase 1b/2a study of OPT-302 in diabetic macular edema patients refractory to anti-VEGF-A therapy, will be presented at the upcoming American Society of Retina Specialists Annual 2020 Virtual Annual Meeting.

RNA-based biopharmaceuticals is a comparatively new class of treatment and it comprises vaccines and therapeutics.

The health system is the network’s first member in the state of Florida

United Therapeutics Corporation announced the United States Patent and Trademark Office issued a new patent on July 21, 2020, relating to Tyvaso® Inhalation Solution. The new patent, U.S. Patent No.